J Clin Oncol 2021 Jul 20
Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial.
Related Questions
The patient had a prior right-sided ER+ HER2-ve breast cancer, treated with neoadjuvant chemotherapy, MRM with ALND, and PMRT
They recently developed...
New comment by Radiation Oncologist at Varian Medical Systems/Allegheny health network ( February 13, 2024)
No change